Israeli Biomed company ConTIPI has been sold for approximately $90 million to an international company whose name has not been disclosed. ConTIPI, founded in 2002 by gynecologists Dr. Ilan Ziv and Zeev Bronfeld, is developing a tampon-like device for the prevention of urine leakage and treatments of faulty functioning of the cervix in women. The sale is subject to approval of the US Food and Drug Administration (FDA) and Office of the Chief Scientist.
Subscribe to NoCamels weekly newsletter and get our top stories
Related posts

‘Stressing Out’ Seaweed Makes It Better For You
March 20, 2023

Time Magazine: Tower Of David One Of World's Greatest Places
March 19, 2023

US Doctors Can Now Diagnose Lung Conditions Remotely
March 16, 2023

Israeli AI Can Identify People With Gambling Addictions
March 16, 2023
Facebook comments